Emerge Commerce Ltd. (ECOM.V)
CAD 0.05
(-10.0%)
CAD 0.05
(-10.0%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 23.82 Million | 58.16 Million | 34.82 Million | 9.2 Million | 4.16 Million | 3.96 Million |
| Cost of Revenue | 11.95 Million | 34.37 Million | 19.71 Million | 2.03 Million | 797.73 Thousand | 578.08 Thousand |
| Gross Profit | 11.87 Million | 23.78 Million | 15.11 Million | 7.17 Million | 3.36 Million | 3.38 Million |
| Operating Expenses | 11.87 Million | 27.9 Million | 19.44 Million | 9.69 Million | 4.87 Million | 103.7 Thousand |
| Selling, General and Administrative Expenses | 10.93 Million | 20.54 Million | 15.47 Million | 8.13 Million | 4.44 Million | 103.7 Thousand |
| Research and Development Expenses | - | 476.03 Thousand | 395.89 Thousand | 300.06 Thousand | - | - |
| Other Expenses | - | 7.35 Million | 3.97 Million | 1.55 Million | 432.47 Thousand | - |
| Cost and Expenses | 26.95 Million | 62.28 Million | 39.16 Million | 11.72 Million | 5.67 Million | 103.7 Thousand |
| Operating Income | 175.02 Thousand | -4.21 Million | -4.36 Million | -2.56 Million | -1.53 Million | -103.71 Thousand |
| Interest Expense | 3.51 Million | 3.54 Million | 1.74 Million | 1.48 Million | - | - |
| Income Tax Expense | -2.26 Million | -1.78 Million | -426.56 Thousand | 209.91 Thousand | 102.9 Thousand | 11.44 Thousand |
| Earnings before Tax | -23.95 Million | -19.16 Million | -6.98 Million | -4.21 Million | -2.94 Million | -132.59 Thousand |
| Net Income | -21.25 Million | -17.38 Million | -6.56 Million | -4.42 Million | -3.04 Million | -132.59 Thousand |
| Earnings Per Share Basic | -0.20 | -0.17 | -0.07 | -0.07 | -4.07 | -0.22 |
| Earnings Per Share Diluted | -0.20 | -0.17 | -0.07 | -0.07 | -4.07 | -0.22 |
| Weighted Average Shares Outstanding | 108.85 Million | 104.22 Million | 95.03 Million | 62.86 Million | 749.99 Thousand | 603.3 Thousand |
| Weighted Average Shares Outstanding (Diluted) | 108.85 Million | 104.22 Million | 95.03 Million | 62.86 Million | 749.99 Thousand | 603.3 Thousand |
| Gross Margin | 0.50 | 0.41 | 0.43 | 0.78 | 0.81 | 0.85 |
| EBIT Margin | -0.66 | 0.05 | -0.01 | -0.11 | -0.26 | -0.03 |
| Profit Margin | -0.89 | -0.30 | -0.19 | -0.48 | -0.73 | -0.03 |
| EBITDA | -15.66 Million | -4.41 Million | -1.16 Million | -1.02 Million | -1.23 Million | -132.59 Thousand |
| Earnings Before Tax Margin | 0.01 | -0.07 | -0.13 | -0.28 | -0.37 | -0.03 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 5.19 Million | 5 Million | 6.21 Million | 23.82 Million | 5.44 Million | 6.16 Million |
| Cost of Revenue | 3.13 Million | 2.92 Million | 3.89 Million | 16.01 Million | 2.66 Million | 3 Million |
| Gross Profit | 2.05 Million | 2.08 Million | 2.32 Million | 7.81 Million | 2.78 Million | 3.16 Million |
| Operating Expenses | 2.22 Million | 2.27 Million | 2.7 Million | 10.93 Million | 3.5 Million | 4.3 Million |
| Selling, General and Administrative Expenses | 2.22 Million | 2.27 Million | 2.7 Million | - | 2.62 Million | 3.07 Million |
| Research and Development Expenses | 393.11 Thousand | 13.42 Thousand | 476.03 Billion | - | - | 210.14 Thousand |
| Other Expenses | 59.53 Thousand | - | - | - | - | - |
| Cost and Expenses | 5.35 Million | 5.19 Million | 6.59 Million | 26.95 Million | 6.17 Million | 7.3 Million |
| Operating Income | -162.07 Thousand | -184.23 Thousand | -379.65 Thousand | -3.12 Million | -822.36 Thousand | -1.16 Million |
| Interest Expense | 292.84 Thousand | 486.73 Thousand | 711.6 Thousand | 3.33 Million | 765.96 Thousand | 774.06 Thousand |
| Income Tax Expense | 36.1 Thousand | -170.48 Thousand | -941.23 Thousand | -2.26 Million | -589.46 Thousand | -608.14 Thousand |
| Earnings before Tax | -627.25 Thousand | -161.04 Thousand | -18.46 Million | -23.95 Million | -1.11 Million | -2.25 Million |
| Net Income | -663.36 Thousand | 81.13 Thousand | -17.94 Million | -22.17 Million | 349.49 Thousand | -1.95 Million |
| Earnings Per Share Basic | -0.01 | 0.00 | -0.15 | - | -0.00 | -0.02 |
| Earnings Per Share Diluted | -0.01 | 0.00 | -0.15 | - | -0.00 | -0.02 |
| Weighted Average Shares Outstanding | 130.12 Million | 123.68 Million | 123.68 Million | 108.85 Million | 118.64 Million | 106.76 Million |
| Weighted Average Shares Outstanding (Diluted) | 130.12 Million | 123.68 Million | 123.68 Million | 108.85 Million | 118.64 Million | 106.76 Million |
| Gross Margin | 0.40 | 0.42 | 0.37 | 0.33 | 0.51 | 0.51 |
| EBIT Margin | -0.02 | 0.00 | 0.18 | - | 0.01 | 0.01 |
| Profit Margin | -0.13 | 0.02 | -2.89 | -0.93 | 0.06 | -0.32 |
| EBITDA | -102.57 Thousand | 8160.00 | 1.13 Million | - | 63.8 Thousand | 59.25 Thousand |
| Earnings Before Tax Margin | -0.03 | -0.04 | -0.06 | -0.13 | -0.15 | -0.19 |
REMEDY
036630
BIOIF
192080
PLTK
ALTRI